Ancora Advisors’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10 Hold
2,791
﹤0.01% 2375
2025
Q4
$24 Hold
2,791
﹤0.01% 2409
2025
Q3
$43 Hold
2,791
﹤0.01% 1936
2025
Q2
$85 Hold
2,791
﹤0.01% 1920
2025
Q1
$100 Hold
2,791
﹤0.01% 1724
2024
Q4
$160 Hold
2,791
﹤0.01% 1751
2024
Q3
$248 Hold
2,791
﹤0.01% 1683
2024
Q2
$204 Hold
2,791
﹤0.01% 1753
2024
Q1
$471 Hold
2,791
﹤0.01% 1684
2023
Q4
$623 Hold
2,791
﹤0.01% 1586
2023
Q3
$586 Sell
2,791
-399
-13% -$99 ﹤0.01% 1617
2023
Q2
$638 Hold
3,190
﹤0.01% 1610
2023
Q1
$520 Sell
3,190
-702
-18% -$127 ﹤0.01% 1722
2022
Q4
$1K Hold
3,892
﹤0.01% 1710
2022
Q3
$1K Hold
3,892
﹤0.01% 1935
2022
Q2
$1K Hold
3,892
﹤0.01% 2118
2022
Q1
$3K Hold
3,892
﹤0.01% 2084
2021
Q4
$3K Hold
3,892
﹤0.01% 2151
2021
Q3
$4K Buy
+3,892
New +$4.69K ﹤0.01% 1964

Ancora Advisors's XAGEW Position: Q1 2026 in Review

Ancora Advisors held its Longevity Health Holdings, Inc. Warrant (XAGEW) position steady in Q1 2026 at 2,791 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

Ancora Advisors first reported a position in XAGEW in Q3 2021 and has held it in 19 quarters since. The position peaked at $4K in Q3 2021. 1 fund tracked by Wall St. Rank holds XAGEW as of Q1 2026.

  • Ancora Advisors held 2,791 shares of Longevity Health Holdings, Inc. Warrant worth $10 as of Q1 2026.
  • Ancora Advisors left its Longevity Health Holdings, Inc. Warrant share count unchanged in Q1 2026.
  • Longevity Health Holdings, Inc. Warrant made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2375 holding.
  • Ancora Advisors first reported a position in Longevity Health Holdings, Inc. Warrant in Q3 2021 and has held it in 19 quarters since.
  • Ancora Advisors's Longevity Health Holdings, Inc. Warrant position peaked at $4K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.